Lemaitre Vascular (LMAT) Gross Profit (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Gross Profit data on file, last reported at $48.4 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $48.4 million, up 16.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $185.5 million (up 19.18% YoY), and the FY2025 annual result was $178.5 million, up 18.32% from the prior year.
• Gross Profit improved to $48.4 million in Q1 2026 per LMAT's latest filing, from $46.2 million in the prior quarter.
• Over five years, Gross Profit peaked at $48.4 million in Q1 2026 and troughed at $25.1 million in Q3 2022.
• A 5-year average of $35.9 million and a median of $36.7 million in 2024 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit increased 0.38% in 2022, then advanced 27.68% in 2023.
• A 5-year view of Gross Profit shows it stood at $26.1 million in 2022, then increased by 27.68% to $33.3 million in 2023, then gained by 16.01% to $38.6 million in 2024, then climbed by 19.69% to $46.2 million in 2025, then gained by 4.78% to $48.4 million in 2026.
• Business Quant data shows LMAT's Gross Profit at $48.4 million in Q1 2026, $46.2 million in Q4 2025, and $46.0 million in Q3 2025.